PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics PE Ratio: 1.031 for March 11, 2024
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| March 11, 2024 | 1.031 |
| March 08, 2024 | 1.031 |
| March 07, 2024 | 1.038 |
| March 06, 2024 | 1.001 |
| March 05, 2024 | 1.001 |
| March 04, 2024 | 0.8315 |
| March 01, 2024 | 0.9346 |
| February 29, 2024 | 0.9113 |
| February 28, 2024 | 0.9113 |
| February 27, 2024 | 0.9942 |
| February 26, 2024 | 0.9942 |
| February 23, 2024 | 0.9663 |
| February 22, 2024 | 0.9413 |
| February 21, 2024 | 0.9413 |
| February 20, 2024 | 1.260 |
| February 16, 2024 | 1.231 |
| February 15, 2024 | 1.231 |
| February 14, 2024 | 1.247 |
| February 13, 2024 | 1.247 |
| February 12, 2024 | 1.247 |
| February 09, 2024 | 1.327 |
| February 08, 2024 | 1.327 |
| February 07, 2024 | 1.327 |
| February 06, 2024 | 1.337 |
| February 05, 2024 | 1.337 |
| Date | Value |
|---|---|
| February 02, 2024 | 1.339 |
| February 01, 2024 | 1.397 |
| January 31, 2024 | 1.400 |
| January 30, 2024 | 1.397 |
| January 29, 2024 | 1.464 |
| January 26, 2024 | 1.537 |
| January 25, 2024 | 1.473 |
| January 24, 2024 | 1.563 |
| January 23, 2024 | 1.580 |
| January 22, 2024 | 1.706 |
| January 19, 2024 | 1.563 |
| January 18, 2024 | 1.563 |
| January 17, 2024 | 1.726 |
| January 16, 2024 | 1.726 |
| January 12, 2024 | 1.596 |
| January 11, 2024 | 1.556 |
| January 10, 2024 | 1.556 |
| January 09, 2024 | 1.53 |
| January 08, 2024 | 1.766 |
| January 05, 2024 | 1.693 |
| January 04, 2024 | 1.700 |
| January 03, 2024 | 1.733 |
| January 02, 2024 | 1.596 |
| December 29, 2023 | 1.477 |
| December 28, 2023 | 1.557 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
0.8315
Minimum
Mar 04 2024
1.766
Maximum
Jan 08 2024
1.453
Average
1.532
Median
Oct 18 2023
PE Ratio Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | -- |
| Genfit SA | -- |
| Innate Pharma SA | -- |
| Inventiva SA | -- |
PE Ratio Related Metrics
| Price to Book Value | 0.4731 |
| Price | 3.10 |
| Earnings Yield | 96.99% |